Sygnature Discovery Limited

2 followers


Sygnature Discovery are a leading drug discovery CRO with expertise across a range of therapeutic and biological target classes. An expert partner in disciplines including Medicinal and Computational Chemistry, In Vitro and In Vivo Pharmacology, DMPK, supported by informatics.

Industries

Headquarters

Stage

Employees

Links

Org chart

Simon Hirst
Founder, CEO & Director

Simon Hirst

Collapse
Paul Overton
CCO & Director
Jonathan Williams
COO & Director
Louisa Jordison
CFO & Director
James Edgar
Chief People Officer
Stuart Onions
SVP, Alliance Management
Iain Walters
Director of Chemistry
Geraint Jones
Director of Chemistry
Colin Sambrook Smith
Director of Computational Sciences & Informatics
Jane Kendrew
Director of Translational Oncology
Allan Jordan
VP, Oncology Drug Discovery
John Unitt
VP, Immunology & Inflammation Drug Discovery
Max Mirza
VP, Neuroscience Drug Discovery
Stephen Young
VP, Business Development
Jon Burke
Marketing Director
Dave Pearson
Director, Form & Formulation
Emily Eaton
Business Development Director